Similar articles for PMID: 16126396

Year	Number of Results
1961	1
1973	1
1980	1
1990	1
1992	1
1993	1
1997	1
1999	3
2000	5
2001	5
2002	5
2003	7
2004	11
2005	11
2006	18
2007	18
2008	16
2009	17
2010	17
2011	6
2012	1
2013	5
2014	2
2015	1
2016	1
2017	2
2018	1
2019	1
2020	1
2021	1
2023	1
2024	0

1

Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.

Cleren C, Starkov AA, Calingasan NY, Lorenzo BJ, Chen J, Beal MF. Cleren C, et al. Neurobiol Dis. 2005 Dec;20(3):701-8. doi: 10.1016/j.nbd.2005.05.022. Epub 2005 Aug 26. Neurobiol Dis. 2005. PMID: 16126396

2

D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.

Muralikrishnan D, Samantaray S, Mohanakumar KP. Muralikrishnan D, et al. Synapse. 2003 Oct;50(1):7-13. doi: 10.1002/syn.10239. Synapse. 2003. PMID: 12872288

3

Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.

Schmidt N, Ferger B. Schmidt N, et al. Synapse. 2001 Apr;40(1):47-54. doi: 10.1002/1098-2396(200104)40:1<47::AID-SYN1025>3.0.CO;2-S. Synapse. 2001. PMID: 11170221

4

Effects of cysteamine on MPTP-induced dopaminergic neurodegeneration in mice.

Sun L, Xu S, Zhou M, Wang C, Wu Y, Chan P. Sun L, et al. Brain Res. 2010 Jun 4;1335:74-82. doi: 10.1016/j.brainres.2010.03.079. Epub 2010 Apr 7. Brain Res. 2010. PMID: 20380823

5

Minocycline enhances MPTP toxicity to dopaminergic neurons.

Yang L, Sugama S, Chirichigno JW, Gregorio J, Lorenzl S, Shin DH, Browne SE, Shimizu Y, Joh TH, Beal MF, Albers DS. Yang L, et al. J Neurosci Res. 2003 Oct 15;74(2):278-85. doi: 10.1002/jnr.10709. J Neurosci Res. 2003. PMID: 14515357

6

Neuroprotection in Parkinson models varies with toxin administration protocol.

Anderson DW, Bradbury KA, Schneider JS. Anderson DW, et al. Eur J Neurosci. 2006 Dec;24(11):3174-82. doi: 10.1111/j.1460-9568.2006.05192.x. Eur J Neurosci. 2006. PMID: 17156378

7

L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.

Saravanan KS, Sindhu KM, Senthilkumar KS, Mohanakumar KP. Saravanan KS, et al. Neurochem Int. 2006 Jul;49(1):28-40. doi: 10.1016/j.neuint.2005.12.016. Epub 2006 Feb 21. Neurochem Int. 2006. PMID: 16490285

8

Amiloride is neuroprotective in an MPTP model of Parkinson's disease.

Arias RL, Sung ML, Vasylyev D, Zhang MY, Albinson K, Kubek K, Kagan N, Beyer C, Lin Q, Dwyer JM, Zaleska MM, Bowlby MR, Dunlop J, Monaghan M. Arias RL, et al. Neurobiol Dis. 2008 Sep;31(3):334-41. doi: 10.1016/j.nbd.2008.05.008. Epub 2008 Jul 7. Neurobiol Dis. 2008. PMID: 18606547

9

Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.

Jakobsen B, Gramsbergen JB, Møller Dall A, Rosenblad C, Zimmer J. Jakobsen B, et al. Eur J Neurosci. 2005 Jun;21(11):2939-48. doi: 10.1111/j.1460-9568.2005.04138.x. Eur J Neurosci. 2005. PMID: 15978005

10

Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson's disease models.

Kim HG, Ju MS, Shim JS, Kim MC, Lee SH, Huh Y, Kim SY, Oh MS. Kim HG, et al. Br J Nutr. 2010 Jul;104(1):8-16. doi: 10.1017/S0007114510000218. Epub 2010 Feb 26. Br J Nutr. 2010. PMID: 20187987

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

149 results

Results by year